Clinical Trial: Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias
Study Status: Completed
Recruit Status: RECRUITING
Condition: Immune Mediated Anemia
Study Type: INTERVENTIONAL
Official Title: A Phase II Study Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-Mediated Cytopenias
Brief Summary:
Background:People who have a blood stem cell transplant can sometimes develop cytopenia.This means that their levels of one or more types of blood cell, such as the red cells or platelets, are lower than they should be.This can occur because a person s immune system might attack these cells after a stem cell transplant.Cytopenia can lead to anemia, severe bleeding, infections, and other problems.Treatments are needed to help keep blood cell levels stable after blood stem cell transplant.Objective:To test a study…
Read more